Generate a tailored SOP for Dr. Wei Tan. Improve your application with a focused, well-structured draft.
Wei Shen Tan is a urologic oncologist with expertise in the treatment of bladder, prostate, and kidney cancers. He completed a Society of Urologic Oncology (SUO)-accredited fellowship at the prestigious University of Texas MD Anderson Cancer Center in Houston, TX, and a robotic urology fellowship at University College London Hospitals in the UK. Dr. Tan finished his residency in Urology at the London School of Surgery and is a Fellow of the Royal College of Surgeons of England. He holds a PhD in Uro-oncology with research focusing on genitourinary cancers, particularly the optimization of treatments for bladder cancer. His key research interests include cancer diagnostics, novel treatments for bladder cancer, and the development of biomarkers. As a co-investigator in major clinical trials, his contributions have resulted in over 100 peer-reviewed publications. In addition to his clinical role, Dr. Tan serves on the editorial boards of notable journals within his field.
Yale School of Medicine • New Haven, CT
Teaching and research in Urology with a focus on urologic oncology.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.